Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a Ready-to-Use Graphical Tool Based on Artificial Neural Network Classification: Application for the Prediction of Late Fecal Incontinence After Prostate Cancer Radiation Therapy.
Carrara M, Massari E, Cicchetti A, Giandini T, Avuzzi B, Palorini F, Stucchi C, Fellin G, Gabriele P, Vavassori V, Degli Esposti C, Cozzarini C, Pignoli E, Fiorino C, Rancati T, Valdagni R. Carrara M, et al. Among authors: giandini t. Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1533-1542. doi: 10.1016/j.ijrobp.2018.07.2014. Epub 2018 Aug 6. Int J Radiat Oncol Biol Phys. 2018. PMID: 30092335
Radiotherapy for unresectable sinonasal cancers: dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy.
Orlandi E, Giandini T, Iannacone E, De Ponti E, Carrara M, Mongioj V, Stucchi C, Tana S, Bossi P, Licitra L, Fallai C, Pignoli E. Orlandi E, et al. Among authors: giandini t. Radiother Oncol. 2014 Nov;113(2):260-6. doi: 10.1016/j.radonc.2014.11.024. Epub 2014 Nov 29. Radiother Oncol. 2014. PMID: 25467003
Hadrontherapy from the Italian Radiation Oncologist point of view: face the reality. The Italian Society of Oncological Radiotherapy (AIRO) survey.
Marvaso G, Vischioni B, Jereczek-Fossa BA, Ciardo D, Fossati P, Giandini T, Morlino S, Carrara M, Romanelli P, Russi E, Valvo F, Valdagni R, Orecchia R. Marvaso G, et al. Among authors: giandini t. Radiol Med. 2017 Feb;122(2):140-145. doi: 10.1007/s11547-016-0699-1. Epub 2016 Oct 21. Radiol Med. 2017. PMID: 27770265
Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G, Jereczek-Fossa BA, Vischioni B, Ciardo D, Giandini T, Hasegawa A, Cattani F, Carrara M, Ciocca M, Bedini N, Villa S, Morlino S, Russo S, Zerini D, Colangione SP, Panaino CMV, Fodor C, Santoro L, Pignoli E, Valvo F, Valdagni R, De Cobelli O, Orecchia R. Marvaso G, et al. Among authors: giandini t. Tumori. 2017 May 12;103(3):314-318. doi: 10.5301/tj.5000587. Epub 2016 Dec 2. Tumori. 2017. PMID: 28009421 Clinical Trial.
Physicists' views on hadrontherapy: a survey of members of the Italian Association of Medical Physics (AIFM).
Giandini T, Tenconi C, Carrara M, Ciocca M, Russo S, Panaino CMV, Cattani F, Ciardo D, Morlino S, Avuzzi B, Bedini N, Villa S, Marvaso G, Romanelli P, Hasegawa A, Vischioni B, Valvo F, Jereczek-Fossa BA, Orecchia R, Valdagni R, Pignoli E. Giandini T, et al. Tumori. 2017 Sep 18;103(5):430-437. doi: 10.5301/tj.5000654. Epub 2017 Jul 8. Tumori. 2017. PMID: 28708234
Patient-reported intestinal toxicity from whole pelvis intensity-modulated radiotherapy: First quantification of bowel dose-volume effects.
Sini C, Noris Chiorda B, Gabriele P, Sanguineti G, Morlino S, Badenchini F, Cante D, Carillo V, Gaetano M, Giandini T, Landoni V, Maggio A, Perna L, Petrucci E, Sacco V, Valdagni R, Rancati T, Fiorino C, Cozzarini C. Sini C, et al. Among authors: giandini t. Radiother Oncol. 2017 Aug;124(2):296-301. doi: 10.1016/j.radonc.2017.07.005. Epub 2017 Jul 21. Radiother Oncol. 2017. PMID: 28739383
Comparison of different treatment planning optimization methods for vaginal HDR brachytherapy with multichannel applicators: A reduction of the high doses to the vaginal mucosa is possible.
Carrara M, Cusumano D, Giandini T, Tenconi C, Mazzarella E, Grisotto S, Massari E, Mazzeo D, Cerrotta A, Pappalardi B, Fallai C, Pignoli E. Carrara M, et al. Among authors: giandini t. Phys Med. 2017 Dec;44:58-65. doi: 10.1016/j.ejmp.2017.11.007. Epub 2017 Nov 20. Phys Med. 2017. PMID: 29254592
30 results